Companies / Avanos Medical, Inc. / Activity
Activity — Avanos Medical, Inc.
20 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | Pacitti David CEO | Grant | Common Stock | $0 | +101K +41.87% | 343,388 0.73% of shares | low |
| Mar 13, 2026 | Hurley John Joseph Executive | Grant | Common Stock | $0 | +2K +19.43% | 13,592 0.03% of shares | low |
| Mar 13, 2026 | Galovan Scott Michael Executive | Grant | Common Stock | $0 | +29K +26.72% | 139,824 0.30% of shares | low |
| Mar 13, 2026 | Delgado Sigfrido Executive | Grant | Common Stock | $0 | +16K +36.01% | 60,005 0.13% of shares | low |
| Mar 6, 2026 | Hurley John Joseph Executive | Other | Common Stock | $2.0K | -144 -1.20% | 11,818 0.03% of shares | low |
| Mar 6, 2026 | Hurley John Joseph Executive | Other | Common Stock | $2.9K | -211 -1.79% | 11,607 0.02% of shares | low |
| Mar 9, 2026 | Hurley John Joseph Executive | Other | Common Stock | $3.0K | -226 -1.95% | 11,381 0.02% of shares | low |
| Mar 6, 2026 | Hurley John Joseph Executive | Other | Common Stock | $4.4K | -321 -2.61% | 11,962 0.03% of shares | low |
| Mar 6, 2026 | Hurley John Joseph Executive | Exercise | Common Stock | $12.7K | +919 +8.09% | 12,283 0.03% of shares | low |
| Mar 6, 2026 | Galovan Scott Michael Executive | Other | Common Stock | $14.6K | -1K -0.92% | 113,503 0.24% of shares | low |
| Mar 9, 2026 | Galovan Scott Michael Executive | Other | Common Stock | $14.9K | -1K -1.00% | 110,343 0.24% of shares | low |
| Mar 6, 2026 | Galovan Scott Michael Executive | Other | Common Stock | $28.1K | -2K -1.80% | 111,462 0.24% of shares | low |
| Mar 6, 2026 | Galovan Scott Michael Executive | Other | Common Stock | $32.5K | -2K -2.02% | 114,560 0.24% of shares | low |
| Mar 6, 2026 | Galovan Scott Michael Executive | Exercise | Common Stock | $81.5K | +6K +5.32% | 116,916 0.25% of shares | low |
| May 8, 2026 | Shimer Julie Ann Director | Grant | Restricted Share Units | — | +12K | 12,003 0.03% of shares | low |
| May 8, 2026 | Oleary Patrick J Director | Grant | Restricted Share Units | — | +12K | 12,003 0.03% of shares | low |
| May 8, 2026 | Blackford Gary Director | Grant | Restricted Share Units | — | +12K | 12,003 0.03% of shares | low |
| Mar 13, 2026 | Pacitti David CEO | Grant | Employee Stock Option (right to buy) | — | +239K | 239,354 0.51% of shares | low |
| Mar 13, 2026 | Galovan Scott Michael Executive | Grant | Employee Stock Option (right to buy) | — | +70K +261.94% | 96,212 0.21% of shares | low |
| Mar 13, 2026 | Delgado Sigfrido Executive | Grant | Employee Stock Option (right to buy) | — | +38K +171.21% | 59,434 0.13% of shares | low |